Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Specimen Handling 219Magnetic Resonance Spectroscopy 196pembrolizumab 195Carboplatin 169Cisplatin 137Biopsy 130Nivolumab 127Paclitaxel 112Cyclophosphamide 109Radiotherapy 104Gemcitabine 103durvalumab 88Dexamethasone 88atezolizumab 75Rituximab 69Radiation 67Lenalidomide 67Pemetrexed 65Doxorubicin 64Bevacizumab 64Docetaxel 61Etoposide 57Ipilimumab 56olaparib 54Fluorouracil 50Prednisone 49Oxaliplatin 49venetoclax 48Taxes 48Radiosurgery 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Tetanus Toxoid × 90 days × Clear all
NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡